SPECIAL REPORT
MOST SHARED
- GE, Comcast Complete Deal Over NBC Universal: Source
- Keeping America Great
- Kohlberg Kravis Bidding for Morgan Stanley's CICC Stake
- Australia Parliament Rejects Carbon Trade Laws
- Toyota Takes Lead Position in Canada in November
- Hyundai's US Auto Sales Jump 46% in November
- New Incentive To Improve... Your Home, That Is!
- Predictions 2010: Technology
- Unemployment to Peak at 10.5%: Moody's Economist
- 8 Stocks to Gain on Obama's Afghan Plan: Analysts
- BofA On Proposed Changes In The Housing Bailout Program
- The Future of The Media Landscape
- November Auto Sales Muddle Along
- Busch: What Obama Won't Say Tonight
- Stick with Equities—Avoid Emerging Markets: Laszlo Birinyi
- Pfizer Chomps On A Carrot
- Predictions 2010: Technology
- GM Removes CEO Henderson; Whitacre is Interim Chief
- Who Were the Biggest Winners And Losers This Year?
- Look Ahead: Markets Count Down to US Jobs Report
- GE, Comcast Complete Deal Over NBC Universal: Source
- US May Raise Rates Before Jobs Recover: Fed's Plosser
- Cramer: Watch Tech Stocks Wednesday
- Stocks Likely Don't Need Santa to Keep Rally Going
- Super Fantasy Christmas Gifts of 2009
- Larry Kudlow's Open Letter to Tiger Woods
PHARMA'S MARKET VIDEO
RSS FEED
Pharma's Market
![]() |
AP New Jersey |
New Jersey, where I live and work, is known as "The World's Medicine Chest" or "The Silicon Valley of Pharma." Johnson and Johnson is headquartered here. Merck calls NJ home. Schering-Plough is based in the Garden State. Celgene headquarters are located a short drive from my house. Wyeth lives here. Sanofi-Aventis, Novartis, Roche, AstraZeneca, and NovoNordisk, just to name a few, all have major operations in Jersey.
Former Goldman Sachs [GS
Loading...
()
] Chairman and now New Jersey Governor Jon Corzine has to be beside himself. His state is already reeling from the banking crisis because of its proximity to and dependence on Wall Street. And now a consolidation wave in big pharma is threatening to take the state under. Gov. Corzine came on CNBC recently and said he was on his knees begging the CEOs of PFE and WYE not to turn Wyeth's sprawling NJ campus into a white elephant. If Merck buys Schering or if, as some analysts are hinting today, JNJ buys Schering you can bet SGP's Kenilworth, NJ HQ will be downsized or shuttered.
Pfizer is HQ'd in Manhattan. It has a big building in midtown within walking distance from Grand Central Station. I get that it's centrally located for a lot of commuters, especially from Long Island, Connecticut and Westchester (kind of a New York City suburb) because trains from those points go straight into Grand Central, but it's gotta be an expensive piece of real estate.
For example, last week I did my interview with new Sanofi-Aventis CEO Chris Viehbacher inside the company's Manhattan office on Park Avenue. I'm told that 500 people used to work there. But since SNY bought Aventis there are now only three people working out of a drastically reduced space. Three people in SNY's NYC office! It's essentially just a small, but nice, prestigious address "for show," for meetings and, I guess, media interviews with execs. Couldn't PFE, which claims it's hyper-focused on cutting costs, do the same by moving folks out of Manhattan to, let's say, Wyeth's buildings in NJ? I'm just asking the question. That's all.
And I'm not just asking because I don't want my property taxes to go up in order to make up for the loss of tax revenue from big pharma evacuating NJ.
By the way, I'm not from Jersey. I'm from L.A., but both of my parents came from Jersey.
Questions? Comments?









